<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102687">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02134860</url>
  </required_header>
  <id_info>
    <org_study_id>H-6-2014-017</org_study_id>
    <nct_id>NCT02134860</nct_id>
  </id_info>
  <brief_title>Bed Rest, Alternate Daily Fasting and Incretin Effect</brief_title>
  <official_title>A Randomized Controlled Study on the Incretin Effect, Cognitive Function and Controlled Fasting During Bed Rest in Healthy Male Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bed rest produces insulin resistance in healthy volunteers. In this study the investigators
      aim to investigate the effect of 8 days bed rest on the incretin effect and how alternate
      daily fasting affects cognitive function and the insulin resistance produced by bed rest.

      The subjects will be randomized to either 3 meals a day (isocaloric diet) or alternate daily
      fasting; one meal/day every second day (50% of daily calorie need) and four meals/day every
      second (150% of daily calorie need).

      The investigators hypothesize:

        1. Bed rest reduces the incretin effect

        2. Alternate  daily fasting improves the cognitive function (memory and concentration)
           compared to isocaloric diet

        3. Alternate daily fasting reduces insulin resistance produced by bed rest compared to
           isocaloric diet
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All subjects will undergo 8 days of bedrest. Outcome measures will be performed before,
      under and immediately after the bed rest period.

      The individual study period will be 10 days in total.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Incretin effect</measure>
    <time_frame>24 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured by Insulin levels during Oral glucose tolerance test (OGTT) and Intravenous glucose tolerance test (IVGTT)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluated by cognitive testing and functional Magnetic Resonance imaging (MRI)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluated by insulin resistance indexes, HOMA-IR and Matsuda index</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Type 2 Diabetes</condition>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 daily meals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Alternate daily fasting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One meal (50% of caloric need) every second day and four meals (150% of caloric need) every second day</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bed rest</intervention_name>
    <description>8 days of full bed rest</description>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_label>Alternate daily fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OGTT</intervention_name>
    <description>Oral glucose tolerance test with 75 g of glucose before and after bed rest</description>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_label>Alternate daily fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IVGTT</intervention_name>
    <description>Intravenous glucose tolerance test mimicking the glucose profile from the corresponding OGTT</description>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_label>Alternate daily fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cognitive testing</intervention_name>
    <description>Daily testing of memory and concentration using standardized tests</description>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_label>Alternate daily fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Muscle and fat biopsies</intervention_name>
    <description>Biopsies will be obtained before and after bed rest</description>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_label>Alternate daily fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dual-energy X-ray Absorptiometry (DXA) scan</intervention_name>
    <description>DXA scan to evaluate fat and muscle distribution before and after bed rest</description>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_label>Alternate daily fasting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>Functional MRI to evaluate cognitive function and abdominal MRI to evaluate visceral fat before and after bed rest</description>
    <arm_group_label>Isocaloric diet</arm_group_label>
    <arm_group_label>Alternate daily fasting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI&lt;25kg/m2

          -  VO2 max normal for age

        Exclusion Criteria:

          -  Tobacco smoking

          -  Alcohol ingestion &gt; 14 units per week

          -  Diabetes in nearby relatives

          -  Pathologic OGTT

          -  Resection of the small intestine

          -  History of gastric bypass surgery

          -  Risk of deep venous thrombosis

          -  Female
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nina Majlund Harder-Lauridsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, 7641</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Signe Tellerup Nielsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, 7641</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rikke Krogh-Madsen, MD. PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, 7641</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bente Klarlund Pedersen, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Rigshospitalet, 7641</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nina Majlund Harder-Lauridsen, MD</last_name>
      <email>mealtrial@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Signe Tellerup Nielsen, MD</last_name>
      <email>pathoscim@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nina Majlund Harder-Lauridsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Signe Tellerup Nielsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 9, 2014</lastchanged_date>
  <firstreceived_date>April 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Anders Rasmussen Rinnov</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Incretins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
